Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metionac in PCOS
NCT05340634Phase 4Completed
- Sponsor
- Margan Biotech
- Start
- Apr 2020
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Margan Biotech. Primary endpoints: Change from Baseline in the Mean BMI at 6 months, Change from Baseline in the Mean Insuline level at 6 months and 5 more. Started Apr 2020; status: completed.
02
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05340634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340634.